ERBB2 and gastric cancer: Due to the great potential of these three markers (HER-2, MMP-2, and MMP-9) in the prognosis and treatment of advanced stages of gastric cancer, and the absence of investigations directly comparing MMP-2 andMMP-9 with HER-2 expression, we decided to evaluate this subject.